Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
2.53M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
26.2M
-
Shares change
-
-1.23M
-
Total reported value, excl. options
-
$12.1M
-
Value change
-
-$449K
-
Number of buys
-
8
-
Number of sells
-
-20
-
Price
-
$0.46
Significant Holders of Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) as of Q4 2023
53 filings reported holding OMIC - Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value as of Q4 2023.
Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.2M shares
.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (4.98M shares), ARCH Venture Management, LLC (3.8M shares), QVIDTVM Management LLC (2.32M shares), UBS Group AG (2.21M shares), PERCEPTIVE ADVISORS LLC (2.13M shares), FMR LLC (2.12M shares), VANGUARD GROUP INC (1.87M shares), Casdin Capital, LLC (1.32M shares), BANK OF MONTREAL /CAN/ (982K shares), and BlackRock Inc. (834K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.